Position in AMGN
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$24,797,977
-$1,765,290 QoQ
Shares Held
68,480
-9.3% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.14%
of 13F equity value
Holder Rank
#339
of 3,140 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Derivatives in AMGN
reported options exposure · as of Dec 31, 2025CallValue
$687,351
CallShares
2,100
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Calamos Advisors LLC holds $812,352,405 across 9 Drug Manufacturers - General names. AMGN ranks #7 (3.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
283,001 | $339,439,917 | |
| 2 | JNJ |
Johnson & Johnson
|
647,222 | $164,374,971 | |
| 3 | ABBV |
AbbVie Inc.
|
399,893 | $100,629,074 | |
| 4 | MRK |
Merck & Co., Inc.
|
650,503 | $83,589,635 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
356,488 | $45,038,693 | |
| 6 | PFE |
Pfizer Inc
|
1,753,548 | $42,225,435 | |
| 7 | AMGN |
Amgen Inc
This page
|
68,480 | $24,797,977 | |
| 8 | BIIB |
Biogen Inc.
|
34,879 | $7,535,956 |
All Filings in AMGN
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,797,977 | 68,480 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $26,563,267 | 75,496 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $22,829,217 | 69,748 | Shares | Sole | 2026-01-29 | |
| 2025-12-31 | $687,351 | 2,100 | Call | Sole | 2026-01-29 | |
| 2025-09-30 | $20,478,971 | 72,569 | Shares | Sole | 2025-10-20 | |
| 2025-09-30 | $564,400 | 2,000 | Call | Sole | 2025-10-20 | |
| 2025-06-30 | $20,193,863 | 72,325 | Shares | Sole | 2025-08-08 | |
| 2025-06-30 | $279,210 | 1,000 | Call | Sole | 2025-08-08 | |
| 2025-03-31 | $22,532,853 | 72,325 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $18,631,850 | 71,485 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $23,033,181 | 71,485 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $22,902,272 | 73,299 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $21,600,359 | 75,972 | Shares | Sole | 2024-05-08 | |
| 2023-12-31 | $22,431,285 | 77,881 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $21,204,357 | 78,897 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $17,523,816 | 78,929 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $19,092,689 | 78,977 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $23,332,674 | 88,839 | Shares | Sole | 2023-01-26 | |
| 2022-09-30 | $23,559,033 | 104,521 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $25,429,959 | 104,521 | Shares | Sole | 2022-08-01 | |
| 2022-03-31 | $24,573,264 | 101,618 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $19,803,884 | 88,029 | Shares | Sole | 2022-02-01 | |
| 2021-09-30 | $17,994,655 | 84,621 | Shares | Sole | 2021-10-26 | |
| 2021-06-30 | $18,806,287 | 77,154 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $14,830,320 | 59,605 | Shares | Sole | 2021-04-12 | |
| 2020-12-31 | $13,280,868 | 57,763 | Shares | Sole | 2021-01-27 | |
| 2020-09-30 | $26,666,721 | 104,921 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $25,994,130 | 110,210 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $23,208,530 | 114,480 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||